JPT Peptide Technologies GmbH


JPT is an ISO 9001 certified provider of innovative peptide products and services and a partner for research projects focusing on applications in Immunology, Immunotherapy & Vaccine Development.
JPT contributes to the effort to combat cancer and infectious diseases with state of the art peptide tools for research, monitoring of clinical trials, and vaccine development. These include our antigen-spanning overlapping peptide pools, or PepMix™ Peptide Pools, for T cell immune monitoring and epitope discovery, our clinical use peptides for immunotherapy including Adoptive Cell Transfer, peptide therapeutics, pulsing of dendritic cells as well as our PepStar™ Peptide Microarrays for seromarker discovery and humoral immune monitoring.
These tools are available as off-the-shelf products, as well as fully customizable solutions for your specific needs.